Evonik, DE000EVNK013

Evonik raises 2026 outlook, shares watched on Xetra after Q2 update

26.06.2026 - 11:39:25 | ad-hoc-news.de

Evonik lifted its 2026 adjusted EBITDA guidance to 2.0 billion euros to 2.2 billion euros in an EQS ad hoc release. The new range is above the prior 1.7 billion euros to 2.0 billion euros target and above the current market view cited by the company.

Evonik, DE000EVNK013
Evonik, DE000EVNK013

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 11:39.

Evonik (DE000EVNK013) raised its 2026 adjusted EBITDA outlook to 2.0 billion euros to 2.2 billion euros in an EQS ad hoc release on Thursday. The company also pointed to a second-quarter adjusted EBITDA range of 600 million euros to 650 million euros, above the 2025 comparable figure, and Reuters-style market readers can place the move on Xetra in the MDAX context.EQS ad hoc via Investing.com

What the update says

The new full-year range compares with the earlier target of 1.7 billion euros to 2.0 billion euros. Evonik said the current market expectation stood at about 567 million euros for the second quarter, based on a Vara Research analyst consensus dated 27 May 2026.

The company now expects first-half 2026 adjusted EBITDA of about 1.1 billion euros. It also flagged a 2026 cash conversion ratio of about 40 percent, versus 37 percent in 2025.

Consensus and trading setup

Jefferies kept its Buy rating on Evonik and left the price target at 20 euros in a note picked up by dpa-AFX on Thursday.dpa-AFX analysis on FinanzNachrichten The same stock page shows Evonik in the MDAX and STOXX Europe 600, which gives the update a clear German market anchor.

Finanzen.net listed the Evonik shares at 16.09 euros on its chart page, up 1.00 percent, with Stuttgart shown as the venue tag on the page.Finanzen.net chart The as-of stamp on that page and the fact box below should be read together.

Go deeper

All news and analysis on the Evonik shares

The ad hoc update and the analyst note point in the same direction, while the chart page gives retail readers a live price reference.

The product behind the stock

Evonik’s portfolio includes specialty additives, animal nutrition products and high-performance materials for industrial customers. The company uses that mix to sell into coatings, construction, automotive and consumer-linked supply chains.

Where the shares trade

The Evonik shares (DE000EVNK013) trade on Xetra at 16.09 euros on 2026-06-26, 11:39 UTC.

Key data on the Evonik shares

  • Company: Evonik Industries AG
  • ISIN: DE000EVNK013
  • Ticker: EVK
  • Trading venue: Xetra
  • Price (as of 2026-06-26, 11:39): 16.09 EUR
  • Sector / industry: Industrials / Chemicals
  • Index membership: MDAX, STOXX Europe 600
  • Next earnings date: 2026-08-04

More on the Evonik shares in social media

Disclaimer: This article is for information only and does not constitute investment advice.

en | DE000EVNK013 | EVONIK | boerse | 69631697 | bgmi